Earnings call transcript: DXC Technology Q4 2026 beats EPS, stock rises

DXC Technology reported Q4 FY2026 EPS of $0.77, beating the $0.70 estimate, while revenue missed slightly at $3.13B versus $3.15B expected and fell 6.6% year over year. Adjusted EBIT margin improved to 7.6% and free cash flow reached $110M for the quarter, supporting a 4.71% share-price gain to $11.47. Management guided FY2027 organic revenue down 3%-5% and EPS of $2.40-$2.90, but highlighted AI-led product launches, cost discipline, and continued debt reduction.

Analysis

DXC’s setup is less a classic earnings beat and more a proof-of-execution story in a low-expectations stock. The market is rewarding the company for showing that margin and cash flow can still expand even when revenue keeps shrinking, but the more important second-order effect is that management is effectively reframing the equity as a cash-return and balance-sheet repair vehicle rather than a growth compounder. That matters because it lowers the hurdle rate for buyback-supported EPS and can keep the stock stable even if top-line deterioration persists for several quarters.

The hidden catalyst is not the FY27 guide itself, but whether AI-driven delivery tools translate from internal productivity into measurable booking quality. If the company really converts more work into small/medium, faster-cycle deals, the mix shift could reduce earnings volatility before it re-accelerates revenue, which is a more realistic path to multiple expansion in this name than a straight-line recovery in legacy project demand. The market is likely underestimating how much of the current decline is contract-ramp math versus structural demand loss; if that distinction holds, the second half of FY27 becomes a sentiment inflection point rather than just a sequencing story.

The key risk is that the “AI transformation” narrative runs ahead of actual conversion, leaving DXC with a prettier cost structure but no durable demand lift. In that case, revenue declines merely slow instead of stop, and the stock remains trapped in a value/serial-underperformer regime where buybacks offset only part of the multiple compression. Time horizon matters: near term, this can grind higher on cash-flow optics; over 6-12 months, the market will demand proof that new offerings are closing deals and not just generating pilot activity.

Key Decisions for Investors

• Long DXC on a 3-6 month horizon into the FY27 second-half inflection story; target a re-rating toward higher single-digit EV/FCF if cash flow stays above $600M and revenue declines stabilize. Use a tight stop if the next quarter shows no improvement in bookings or GIS deterioration worsens.
• Buy DXC Jan-2027 call spreads financed by selling near-dated upside to express a slow-burn turnaround with limited downside. Best risk/reward is if the market starts pricing FY28 margin expansion before revenue turns positive.
• Pair trade: long DXC / short a higher-multiple IT services peer with more exposure to discretionary project spend. The edge is relative defensiveness in cash generation and capital returns versus names where any slowdown directly hits valuation.
• Avoid chasing the post-earnings gap unless the stock holds above the immediate reaction high for several sessions; otherwise expect mean reversion if the market decides the beat was purely cost-driven. Re-enter on a pullback if management shows evidence of bookings conversion in the next update.
• For event-driven accounts, use DXC as a catalyst trade into Investor Day on June 11: accumulate before the event, then trim into strength unless management quantifies pipeline-to-revenue conversion and AI-related mix contribution.